Menu Philippe 4
4 · SOPHiA GENETICS SA · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 5,000 Shares
What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 5,000 shares on May 26, 2026 in open-market transactions for a total of approximately $24,774. The reported weighted-average price was $4.95 per share (individual trades ranged from $4.78 to $5.01). This was a sale (routine liquidity) rather than a purchase.
Key Details
- Transaction date: 2026-05-26. Filed with the SEC on 2026-06-01 (appears later than the typical 2-business-day Form 4 deadline).
- Shares sold: 5,000; weighted-average price: $4.95; total proceeds reported: $24,774.
- Price range: trades occurred at prices from $4.78 to $5.01 (footnote says breakdown by price available on request).
- Footnotes: F1 — sale executed pursuant to a pre-established Rule 10b5-1(c) trading plan; F2 — weighted-average price with multiple execution prices and offer to provide per-price breakdown.
- Shares owned after the transaction: not disclosed in the provided filing excerpt.
Context
Sales made under a 10b5-1 plan are pre-planned transactions that can reflect scheduled liquidity or diversification and are generally considered less indicative of new insider sentiment about the company. This report shows a routine disposition rather than an acquisition or option exercise.
Insider Transaction Report
Form 4
Menu Philippe
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-05-26$4.95/sh−5,000$24,774→ 250,780 total
Footnotes (2)
- [F1]Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.78 to $5.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Philippe Menu|2026-06-01